Skip to main content
Erschienen in: Heart and Vessels 7/2016

29.07.2015 | Original Article

Incidence and predictors of ischemic stroke during hospitalization for congestive heart failure

Erschienen in: Heart and Vessels | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Abstract

Heart failure (HF) increases the risk of ischemic stroke. Data regarding the incidence and predictors of ischemic stroke during hospitalization for HF are limited. The study population of this retrospective cohort study consisted of patients with congestive HF, consecutively admitted to our center from October 2010 to April 2014. We excluded patients complicated with acute myocardial infarction, infective endocarditis, and takotsubo cardiomyopathy. We also excluded those with dialysis or mechanical circulatory support. We investigated the incidence of ischemic stroke during hospitalization for HF. Thereafter, we divided the patients without oral anticoagulants at admission into two groups: patients with ischemic stroke and those without it, and explored the predictors of ischemic stroke. A total of 558 patients (287 without atrial fibrillation (AF), 271 with AF) were enrolled. The mean age was 76.8 ± 12.3 years, and 244 patients (44 %) were female. The mean left-ventricular ejection fraction was 47.4 %. Oral anticoagulants were prescribed in 147 patients (8 without AF, 139 with AF). During hospitalization (median length 18 days), symptomatic ischemic stroke (excluding catheter-related) occurred in 15 patients (2.7 % of the total, 8 without AF, 7 with AF). Predictors significantly associated with increased risk of ischemic stroke in patients without oral anticoagulants were as follows; short-term increases in blood urea nitrogen after admission (at day 3; odds ratio (per 1 md/dl): 1.06, 95 % confidence interval (CI) 1.01–1.11, p = 0.02, and at day 7; odds ratio: 1.03, 95 % CI 1.00–1.07, p = 0.03, respectively), and previous stroke (odds ratio; 3.33, 95 % CI 1.01–11.00, p = 0.04). The incidence of ischemic stroke during hospitalization for HF was high, even in patients without AF. Previous stroke and short-term increases in blood urea nitrogen was significantly associated with the incidence of ischemic stroke.
Literatur
1.
Zurück zum Zitat McCullough PA, Philbin EF, Spertus JA, Kaatz S, Sandberg KR, Weaver WD (2002) Confirmation of a heart failure epidemic: findings from the resource utilization among congestive heart failure (REACH) study. J Am Coll Cardiol 39:60–69CrossRefPubMed McCullough PA, Philbin EF, Spertus JA, Kaatz S, Sandberg KR, Weaver WD (2002) Confirmation of a heart failure epidemic: findings from the resource utilization among congestive heart failure (REACH) study. J Am Coll Cardiol 39:60–69CrossRefPubMed
2.
Zurück zum Zitat Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22:983–988CrossRefPubMed Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22:983–988CrossRefPubMed
3.
Zurück zum Zitat Witt BJ, Brown RD Jr, Jacobsen SJ, Weston SA, Ballman KV, Meverden RA, Roger VL (2006) Ischemic stroke after heart failure: a community-based study. Am Heart J 152:102–109CrossRefPubMed Witt BJ, Brown RD Jr, Jacobsen SJ, Weston SA, Ballman KV, Meverden RA, Roger VL (2006) Ischemic stroke after heart failure: a community-based study. Am Heart J 152:102–109CrossRefPubMed
4.
Zurück zum Zitat Hart RG, Pearce LA, Aguilar MI (2007) Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 146:857–867CrossRefPubMed Hart RG, Pearce LA, Aguilar MI (2007) Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 146:857–867CrossRefPubMed
5.
Zurück zum Zitat Massie BM, Collins JF, Ammon SE, Armstrong PW, Cleland JG, Ezekowitz M, Jafri SM, Krol WF, O’Connor CM, Schulman KA, Teo K, Warren SR (2009) Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the warfarin and antiplatelet therapy in chronic heart failure (WATCH) trial. Circulation 119:1616–1624CrossRefPubMed Massie BM, Collins JF, Ammon SE, Armstrong PW, Cleland JG, Ezekowitz M, Jafri SM, Krol WF, O’Connor CM, Schulman KA, Teo K, Warren SR (2009) Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the warfarin and antiplatelet therapy in chronic heart failure (WATCH) trial. Circulation 119:1616–1624CrossRefPubMed
6.
Zurück zum Zitat Homma S, Thompson JL, Pullicino PM, Levin B, Freudenberger RS, Teerlink JR, Ammon SE, Graham S, Sacco RL, Mann DL, Mohr JP, Massie BM, Labovitz AJ, Anker SD, Lok DJ, Ponikowski P, Estol CJ, Lip GY, Di Tullio MR, Sanford AR, Mejia V, Gabriel AP, del Valle ML, Buchsbaum R (2012) Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med 366:1859–1869CrossRefPubMedPubMedCentral Homma S, Thompson JL, Pullicino PM, Levin B, Freudenberger RS, Teerlink JR, Ammon SE, Graham S, Sacco RL, Mann DL, Mohr JP, Massie BM, Labovitz AJ, Anker SD, Lok DJ, Ponikowski P, Estol CJ, Lip GY, Di Tullio MR, Sanford AR, Mejia V, Gabriel AP, del Valle ML, Buchsbaum R (2012) Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med 366:1859–1869CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Vemmos K, Ntaios G, Savvari P, Vemmou AM, Koroboki E, Manios E, Kounali A, Lip GY (2012) Stroke aetiology and predictors of outcome in patients with heart failure and acute stroke: a 10-year follow-up study. Eur J Heart Fail 14:211–218CrossRefPubMed Vemmos K, Ntaios G, Savvari P, Vemmou AM, Koroboki E, Manios E, Kounali A, Lip GY (2012) Stroke aetiology and predictors of outcome in patients with heart failure and acute stroke: a 10-year follow-up study. Eur J Heart Fail 14:211–218CrossRefPubMed
8.
Zurück zum Zitat Alberts VP, Bos MJ, Koudstaal P, Hofman A, Witteman JC, Stricker B, Breteler M (2010) Heart failure and the risk of stroke: the rotterdam study. Eur J Epidemiol 25:807–812CrossRefPubMedPubMedCentral Alberts VP, Bos MJ, Koudstaal P, Hofman A, Witteman JC, Stricker B, Breteler M (2010) Heart failure and the risk of stroke: the rotterdam study. Eur J Epidemiol 25:807–812CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Lip GY, Rasmussen LH, Skjoth F, Overvad K, Larsen TB (2012) Stroke and mortality in patients with incident heart failure: The diet, cancer and health (DCH) cohort study. BMJ Open 2 Lip GY, Rasmussen LH, Skjoth F, Overvad K, Larsen TB (2012) Stroke and mortality in patients with incident heart failure: The diet, cancer and health (DCH) cohort study. BMJ Open 2
10.
Zurück zum Zitat Yetkin E, Topal E, Yanik A, Ozten M (2010) Thromboembolic complications in patients with newly diagnosed dilated cardiomyopathy immediately after initiation of congestive heart failure treatment: just a coincidence or should we pay more attention? Clin Appl Thromb Hemost 16:480–482CrossRefPubMed Yetkin E, Topal E, Yanik A, Ozten M (2010) Thromboembolic complications in patients with newly diagnosed dilated cardiomyopathy immediately after initiation of congestive heart failure treatment: just a coincidence or should we pay more attention? Clin Appl Thromb Hemost 16:480–482CrossRefPubMed
11.
12.
Zurück zum Zitat McKee PA, Castelli WP, McNamara PM, Kannel WB (1971) The natural history of congestive heart failure: the Framingham study. N Engl J Med 285:1441–1446CrossRefPubMed McKee PA, Castelli WP, McNamara PM, Kannel WB (1971) The natural history of congestive heart failure: the Framingham study. N Engl J Med 285:1441–1446CrossRefPubMed
13.
Zurück zum Zitat Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Toast. Trial of org 10172 in acute stroke treatment. Stroke 24:35–41CrossRefPubMed Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Toast. Trial of org 10172 in acute stroke treatment. Stroke 24:35–41CrossRefPubMed
14.
Zurück zum Zitat Fuchs S, Stabile E, Kinnaird TD, Mintz GS, Gruberg L, Canos DA, Pinnow EE, Kornowski R, Suddath WO, Satler LF, Pichard AD, Kent KM, Weissman NJ (2002) Stroke complicating percutaneous coronary interventions: incidence, predictors, and prognostic implications. Circulation 106:86–91CrossRefPubMed Fuchs S, Stabile E, Kinnaird TD, Mintz GS, Gruberg L, Canos DA, Pinnow EE, Kornowski R, Suddath WO, Satler LF, Pichard AD, Kent KM, Weissman NJ (2002) Stroke complicating percutaneous coronary interventions: incidence, predictors, and prognostic implications. Circulation 106:86–91CrossRefPubMed
15.
Zurück zum Zitat Bettari L, Fiuzat M, Becker R, Felker GM, Metra M, O’Connor CM (2011) Thromboembolism and antithrombotic therapy in patients with heart failure in sinus rhythm: current status and future directions. Circ Heart Fail 4:361–368CrossRefPubMed Bettari L, Fiuzat M, Becker R, Felker GM, Metra M, O’Connor CM (2011) Thromboembolism and antithrombotic therapy in patients with heart failure in sinus rhythm: current status and future directions. Circ Heart Fail 4:361–368CrossRefPubMed
16.
Zurück zum Zitat Lip GY, Piotrponikowski P, Andreotti F, Anker SD, Filippatos G, Homma S, Morais J, Pullicino P, Rasmussen LH, Marin F, Lane DA (2012) Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the esc heart failure association and the esc working group on thrombosis. Thromb Haemost 108:1009–1022CrossRefPubMed Lip GY, Piotrponikowski P, Andreotti F, Anker SD, Filippatos G, Homma S, Morais J, Pullicino P, Rasmussen LH, Marin F, Lane DA (2012) Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the esc heart failure association and the esc working group on thrombosis. Thromb Haemost 108:1009–1022CrossRefPubMed
17.
Zurück zum Zitat Sato N, Kajimoto K, Keida T, Mizuno M, Minami Y, Yumino D, Asai K, Murai K, Muanakata R, Aokage T, Sakata Y, Mizuno K, Takano T (2013) Clinical features and outcome in hospitalized heart failure in japan (from the ATTEND registry). Circ J 77:944–951CrossRefPubMed Sato N, Kajimoto K, Keida T, Mizuno M, Minami Y, Yumino D, Asai K, Murai K, Muanakata R, Aokage T, Sakata Y, Mizuno K, Takano T (2013) Clinical features and outcome in hospitalized heart failure in japan (from the ATTEND registry). Circ J 77:944–951CrossRefPubMed
18.
Zurück zum Zitat Hamaguchi S, Kinugawa S, Tsuchihashi-Makaya M, Goto D, Yamada S, Yokoshiki H, Tsutsui H (2013) Characteristics, management, and outcomes for patients during hospitalization due to worsening heart failure-a report from the japanese cardiac registry of heart failure in cardiology (JCARE-CARD). J Cardiol 62:95–101CrossRefPubMed Hamaguchi S, Kinugawa S, Tsuchihashi-Makaya M, Goto D, Yamada S, Yokoshiki H, Tsutsui H (2013) Characteristics, management, and outcomes for patients during hospitalization due to worsening heart failure-a report from the japanese cardiac registry of heart failure in cardiology (JCARE-CARD). J Cardiol 62:95–101CrossRefPubMed
19.
Zurück zum Zitat Sabit R, Thomas P, Shale DJ, Collins P, Linnane SJ (2010) The effects of hypoxia on markers of coagulation and systemic inflammation in patients with copd. Chest 138:47–51CrossRefPubMed Sabit R, Thomas P, Shale DJ, Collins P, Linnane SJ (2010) The effects of hypoxia on markers of coagulation and systemic inflammation in patients with copd. Chest 138:47–51CrossRefPubMed
20.
Zurück zum Zitat Haeusler KG, Laufs U, Endres M (2011) Chronic heart failure and ischemic stroke. Stroke 42:2977–2982CrossRefPubMed Haeusler KG, Laufs U, Endres M (2011) Chronic heart failure and ischemic stroke. Stroke 42:2977–2982CrossRefPubMed
21.
Zurück zum Zitat Freudenberger RS, Schumaecker MM, Homma S (2010) What is the appropriate approach to prevention of thromboembolism in heart failure? Thromb Haemost 103:489–495CrossRefPubMed Freudenberger RS, Schumaecker MM, Homma S (2010) What is the appropriate approach to prevention of thromboembolism in heart failure? Thromb Haemost 103:489–495CrossRefPubMed
22.
Zurück zum Zitat Di Mascio R, Marchioli R, Vitullo F, Tognoni G (1996) A positive relation between high hemoglobin values and the risk of ischemic stroke. Progetto 3a investigators. Eur Neurol 36:85–88CrossRefPubMed Di Mascio R, Marchioli R, Vitullo F, Tognoni G (1996) A positive relation between high hemoglobin values and the risk of ischemic stroke. Progetto 3a investigators. Eur Neurol 36:85–88CrossRefPubMed
23.
Zurück zum Zitat Yasaka M, Beppu S (1993) Hypercoagulability in the left atrium: part II: coagulation factors. J Heart Valve Dis 2:25–34PubMed Yasaka M, Beppu S (1993) Hypercoagulability in the left atrium: part II: coagulation factors. J Heart Valve Dis 2:25–34PubMed
24.
Zurück zum Zitat Yamada H, Sugiyama T, Ashida T, Fujii J (1998) Sustained hemoconcentration in patients with chronic atrial fibrillation, a potential risk for stroke and thromboembolic complications. A retrospective study. Jpn Heart J 39:715–720CrossRefPubMed Yamada H, Sugiyama T, Ashida T, Fujii J (1998) Sustained hemoconcentration in patients with chronic atrial fibrillation, a potential risk for stroke and thromboembolic complications. A retrospective study. Jpn Heart J 39:715–720CrossRefPubMed
25.
Zurück zum Zitat Rodriguez GJ, Cordina SM, Vazquez G, Suri MF, Kirmani JF, Ezzeddine MA, Qureshi AI (2009) The hydration influence on the risk of stroke (thirst) study. Neurocrit Care 10:187–194CrossRefPubMed Rodriguez GJ, Cordina SM, Vazquez G, Suri MF, Kirmani JF, Ezzeddine MA, Qureshi AI (2009) The hydration influence on the risk of stroke (thirst) study. Neurocrit Care 10:187–194CrossRefPubMed
26.
Zurück zum Zitat Gillum RF, Sempos CT (1996) Hemoglobin, hematocrit, and stroke incidence and mortality in women and men. Stroke 27:1910PubMed Gillum RF, Sempos CT (1996) Hemoglobin, hematocrit, and stroke incidence and mortality in women and men. Stroke 27:1910PubMed
27.
Zurück zum Zitat Wannamethee SG, Shaper AG, Perry IJ (1997) Serum creatinine concentration and risk of cardiovascular disease: a possible marker for increased risk of stroke. Stroke 28:557–563CrossRefPubMed Wannamethee SG, Shaper AG, Perry IJ (1997) Serum creatinine concentration and risk of cardiovascular disease: a possible marker for increased risk of stroke. Stroke 28:557–563CrossRefPubMed
28.
Zurück zum Zitat Mano Y, Koide K, Sukegawa H, Kodaira M, Ohki T (2014) Successful resolution of a left ventricular thrombus with apixaban treatment following acute myocardial infarction. Heart Vessels. doi:10.1007/s00380-014-0562-z Mano Y, Koide K, Sukegawa H, Kodaira M, Ohki T (2014) Successful resolution of a left ventricular thrombus with apixaban treatment following acute myocardial infarction. Heart Vessels. doi:10.​1007/​s00380-014-0562-z
29.
Zurück zum Zitat Nagamoto Y, Shiomi T, Matsuura T, Okahara A, Takegami K, Mine D, Shirahama T, Koga Y, Yoshida K, Sadamatsu K, Hayashida K (2014) Resolution of a left ventricular thrombus by the thrombolytic action of dabigatran. Heart Vessels 29:560–562CrossRefPubMed Nagamoto Y, Shiomi T, Matsuura T, Okahara A, Takegami K, Mine D, Shirahama T, Koga Y, Yoshida K, Sadamatsu K, Hayashida K (2014) Resolution of a left ventricular thrombus by the thrombolytic action of dabigatran. Heart Vessels 29:560–562CrossRefPubMed
30.
Zurück zum Zitat Ogilvie IM, Newton N, Welner SA, Cowell W, Lip GY (2014) Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med 123:638–645CrossRef Ogilvie IM, Newton N, Welner SA, Cowell W, Lip GY (2014) Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med 123:638–645CrossRef
Metadaten
Titel
Incidence and predictors of ischemic stroke during hospitalization for congestive heart failure
Publikationsdatum
29.07.2015
Erschienen in
Heart and Vessels / Ausgabe 7/2016
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-015-0719-4

Weitere Artikel der Ausgabe 7/2016

Heart and Vessels 7/2016 Zur Ausgabe

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Komplette Revaskularisation bei Infarkt: Neue Studie setzt ein Fragezeichen

24.04.2024 ACC 2024 Nachrichten

Eine FFR-gesteuerte komplette Revaskularisation war in einer Studie bei Patienten mit akutem Myokardinfarkt und koronarer Mehrgefäßerkrankung klinisch nicht wirksamer als eine alleinige Revaskularisation der Infarktarterie.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.